FDA Inspection 796524 — Regenerative Biologics, Inc.
The FDA completed an inspection of Regenerative Biologics, Inc. on August 29, 2012 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 29, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Melbourne, FL (United States)